Gentian Diagnostics ASA (OSL:GENT)

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 43.92M NOK in the quarter ending March 31, 2026, a decrease of -1.31%. This brings the company's revenue in the last twelve months to 175.92M, up 11.29% year-over-year. In the year 2025, Gentian Diagnostics ASA had annual revenue of 176.50M with 16.07% growth.

• Revenue (ttm): 175.92M
• Revenue Growth: +11.29%
• P/S Ratio: 3.43
• Revenue / Employee: 2.75M
• Employees: 64
• Market Cap: 602.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	176.50M	24.43M	16.07%
Dec 31, 2024	152.07M	16.92M	12.52%
Dec 31, 2023	135.15M	23.23M	20.76%
Dec 31, 2022	111.92M	11.91M	11.91%
Dec 31, 2021	100.01M	21.13M	26.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error